Infectious Complications After Esophagectomy
CIFO
Infectious Complications, Associated Factors, and Prognosis After Esophagectomy for Cancer: A French, Multicenter, Retrospective Study - CIFO-study
1 other identifier
observational
350
1 country
2
Brief Summary
Infectious complications represent the most common postoperative adverse events following esophagectomy for cancer, such as pneumonia (15% of cases). These complications increase immediate risks, lengthen hospital stays, and worsen patient quality of life. The population includes patients admitted to intensive care after esophagectomy for cancer between January 1, 2017, and December 31, 2024. The study focuses on this population due to the increasing incidence of esophageal cancer, the increased use of surgery for these indications, and the importance of postoperative infections in these complex procedures, despite their understudied nature in the current literature. Identifying modifiable risk factors could lead to corrective measures and thus improve the prognosis of postoperative patients. The research focuses primarily on the incidence, types, factors, and prognosis associated with the occurrence of infections after esophagectomy for cancer. It also includes an analysis of the pathogens involved, their resistance profiles, and the antibiotic therapies used in first-line probabilistic treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
August 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 28, 2026
December 17, 2025
December 1, 2025
11 months
March 13, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of infections after esophagectomy for cancer
until the day 28
Secondary Outcomes (5)
Number of postoperative infectious episodes per participant, classified by anatomical site, as assessed retrospectively from hospitalization records
until the day 28
Presence of predefined pathogens during postoperative infectious episodes, as assessed retrospectively from hospitalization records
until the day 28
Association between preoperative and perioperative clinical variables and the occurrence of postoperative infection, as assessed by multivariable logistic regression analysis of hospitalization records
until the day 28
Occurrence of major complications (sepsis, septic shock, AKI, ARDS, or death) within 28 days after esophagectomy, as documented in hospitalization records, compared between infected and non-infected patients
until day 28
Association between postoperative infection and length of hospital stay, as assessed by linear regression analysis of hospitalization records
until day 28
Eligibility Criteria
Hospitalized patients in intensive care unity.
You may qualify if:
- Patients over 18 years of age
- Underwent esophagectomy for cancer between January 1, 2017, and December 31, 2024
- Scheduled admission to intensive care for postoperative monitoring
You may not qualify if:
- Opposition to the use of data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital Saint-Louis - APHP
Paris, 75010, France
Saint Louis Hospital
Paris, 75010, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François DEPRET, MD-PHD
APHP
- PRINCIPAL INVESTIGATOR
DEPRET
APHP
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2025
First Posted
April 4, 2025
Study Start
August 27, 2025
Primary Completion (Estimated)
July 28, 2026
Study Completion (Estimated)
July 28, 2026
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share